MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
10.46
-0.30 (-2.79%)
Sep 25, 2026, 4:00 PM EDT - Market closed
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $581.32 million as of September 25, 2026.
Market Cap
581.32M
Enterprise Value
278.58M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.46
ChartMarket Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has decreased from $704.29M to $581.32M, a decrease of -17.46%. That is a compound annual growth rate of -18.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 581.32M | -24.16% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 609.20M |
| Crescent Biopharma | 598.79M |
| Altimmune | 595.22M |
| CytomX Therapeutics | 588.33M |
| Phathom Pharmaceuticals | 579.84M |
| Valneva SE | 574.88M |
| Sagimet Biosciences | 574.35M |
| Oculis Holding AG | 572.26M |